Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
3.200
-0.090 (-2.74%)
Jul 14, 2026, 11:42 AM EDT - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $61.03 million as of July 14, 2026. Its market cap has decreased by -52.39% in one year.
Market Cap
61.03M
Enterprise Value
62.14M
1-Year Change
-52.39%
Ranking
Category
Stock Price
$3.20
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $61.03M, a decrease of -80.45%. That is a compound annual growth rate of -40.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 66.37M | -52.29% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 71.23M |
| MindWalk Holdings | 71.02M |
| XBiotech | 69.82M |
| Pliant Therapeutics | 68.82M |
| MediciNova | 68.42M |
| ImageneBio | 66.66M |
| Cingulate | 66.13M |
| PMV Pharmaceuticals | 66.13M |